In our latest insight, we reflect on what we’re seeing in the region, from Saudi Arabia’s Vision 2030 to the UAE’s push for innovation and value in healthcare.

What’s behind Trump’s drug pricing proposal? This insight explores key policy tools, global scenarios, and long-term ...

Spending Review: £29bn for NHS. OHE’s Graham Cookson calls for clarity on productivity and investment in prevention for ...

Antimicrobial resistance (AMR) is a global health crisis, projected to cause up to 10 million deaths annually and impose economic costs exceeding $150 billion by 2050.

As healthcare systems outside of the US strive to allocate resources efficiently, the use of economic evaluation metrics like Quality-Adjusted Life Years (QALYs) has become increasingly common. QALYs ...

OHE Expert Profile Hugh Gravelle Hugh Gravelle – Centre for Health Economics, University of York ...